Challenges in Identifying New Antimicrobial Agents Effective for Treating Infections with Acinetobacter baumannii and Pseudomonas aeruginosa
Open Access
- 1 September 2006
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 43 (Supplement) , S100-S105
- https://doi.org/10.1086/504487
Abstract
Acinetobacter baumannii and Pseudomonas aeruginosa are gram-negative pathogens that target immunocompromised patients. They express a variety of deteKeywords
This publication has 46 references indexed in Scilit:
- Occurrence of HypermutablePseudomonas aeruginosain Cystic Fibrosis Patients Is Associated with the Oxidative Stress Caused by Chronic Lung InflammationAntimicrobial Agents and Chemotherapy, 2005
- Multidrug-ResistantAcinetobacter baumanniiEmerging Infectious Diseases, 2005
- National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004American Journal of Infection Control, 2004
- The changing face of malignant (necrotising) external otitis: clinical, radiological, and anatomic correlationsPublished by Elsevier ,2004
- Molecular Basis of Bacterial Outer Membrane Permeability RevisitedMicrobiology and Molecular Biology Reviews, 2003
- Clinical impact of pneumonia caused by Acinetobacter baumannii in intubated patients: A matched cohort study*Critical Care Medicine, 2003
- Review of the Incidence and Prognosis of Pseudomonas aeruginosa Infections in Cancer Patients in the 1990sEuropean Journal of Clinical Microbiology & Infectious Diseases, 2000
- Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactamThe Lancet, 1994
- Imipenem resistance in pseudomonas aeruginosa PAO: mapping of the OprD2 geneAntimicrobial Agents and Chemotherapy, 1991
- Pseudomonas Bacteremia in Patients with Malignant DiseasesThe Lancet Healthy Longevity, 1970